Literature DB >> 4767675

[Cefazolin, a new broad-spectrum antibiotic (author's transl)].

C Simon, V Malerczyk, E Brahmstaedt, W Toeller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4767675     DOI: 10.1055/s-0028-1107275

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  11 in total

1.  Pharmacokinetics of Bay k 4999, a new broad-spectrum penicillin.

Authors:  R Wise; B Cadge; A P Gillett; A Bhamjee; R Livingston; P G Welling; D P Thornhill
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

2.  Comparison of cefotaxime and moxalactam pharmacokinetics and tissue levels.

Authors:  R Wise; S Baker; R Livingston
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

3.  Simultaneous comparison of three methods for assessing ceftazidime penetration into extravascular fluid.

Authors:  D M Ryan; B Hodges; G R Spencer; S M Harding
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

Review 4.  Choice among penicillins and cephalosporins.

Authors:  L P Garrod
Journal:  Br Med J       Date:  1974-07-13

5.  Concentrations of cefazolin in human skeletal muscle.

Authors:  E Sinagowitz; K Pelz; A Burgert; W Kaczkowski
Journal:  Infection       Date:  1976       Impact factor: 3.553

6.  The effect of probenecid on the pharmacokinetics and distribution of cefoxitin in healthy volunteers.

Authors:  D S Reeves; D W Bullock; M J Bywater; H A Holt; L O White; D P Thornhill
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

7.  Cefazolin and cephradine: relationship between serum concentrations and tissue contents in mice.

Authors:  M W Kunst; H Mattie
Journal:  Infection       Date:  1978       Impact factor: 3.553

8.  Pharmacological study of cefazolin during intermittent and continuous infusion: a crossover investigation in humans.

Authors:  J P Thys; B Vanderkelen; J Klastersky
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

9.  Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporin.

Authors:  M Seddon; R Wise; A P Gillett; R Livingston
Journal:  Antimicrob Agents Chemother       Date:  1980-08       Impact factor: 5.191

10.  [An investigation into the influence of human serum on the in-vitro activity of various cephalosporins (author's transl)].

Authors:  R Ratschow; J R Krone
Journal:  Infection       Date:  1977       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.